UPC APP 56246/2024
EP4183412 Unitary patent · RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
- Case details
- StatusClaim dismissedActionPreliminary objectionCategoryPreliminary objection
- Parties
- Claimants
- GlaxoSmithKline Biologicals SAOperating co.
Representatives- Daniela Kinkeldey-Bird & Bird LLP
Respondents- Pfizer Manufacturing Belgium NVOperating co.
- Pfizer Inc.Operating co.
- Pfizer Europe MA EEIGOperating co.
- Pfizer S.A.Operating co.
- Pfizer LimitedOperating co.
- Pfizer Pharma GmbHOperating co.
- Pfizer Service Company S.R.L.Operating co.
- Pfizer B.V.Operating co.
Representatives- Gareth Owen Williams-Marks & Clerk LLP
- Division
- Milan CD
- Judges
- —
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- —
- First decided
- Dec 3, 2024
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Milan CD | Locked |
At the UPC: GlaxoSmithKline Biologicals SA (20 cases)·Pfizer Group (31 cases)
This dispute contains 7 other proceedings
UPC CFI 476/2024·UPC CFI 468/2024·UPC APP 16306/2025·UPC APP 16366/2025·UPC APP 17607/2025 and 2 more
1 other defendants litigating the same or a related patent
- 2024-12-03Preliminary objectionPublic
Summary: The Milan Central Division rejected GlaxoSmithKline Biologicals S.A.'s preliminary objection (R. 19 RoP) in the revocation action UPC_CFI_476/2024 (EP 4 183 412 — a vaccine-related patent owned by GSK). GSK argued that a parallel infringement action by Pfizer before the Düsseldorf Local Division challenged the Central Division's competence over the revocation action. The Court held that the infringement action appeared inadmissible when lodged (filed on 5 August 2024, before the patent was granted on 14 August 2024) and therefore could not challenge the Central Division's competence over the revocation action under Art. 33 UPCA. The request for a hearing before deciding the preliminary objection was also rejected.
Show the legal issues (4)
- Preliminary objection under R. 19 RoP — competence of Central Division
- Admissibility of infringement action filed before patent grant
- Art. 33 UPCA — relationship between infringement action and Central Division revocation jurisdiction
- Parallel proceedings and lis pendens
- E5F84BB34BE6B6DCC0F5EB99378AB579_en.pdf2024-12-03EN